Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NGN Capital invests in a broad range of healthcare and biotechnology segments, primarily targeting later-stage opportunities while also considering selected early-stage investments. Their strategy aims for above-average private equity returns through a diversified portfolio that includes drug products, medical devices, and healthcare services.
Kenneth S. Abramowitz - Managing General Partner with extensive experience in healthcare investments. John R. Costantino - Managing General Partner focused on biotech opportunities. Peter Johann - Managing General Partner with a background in healthcare services.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.